南アフリカ - 英語 - South African Health Products Regulatory Authority (SAHPRA)

novartis south africa (pty) ltd - tablet - each tablet contains fluvastatin sodium equivalent to fluvastatin 80,0 mg

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

b & s healthcare - fluvastatin sodium - tablet prolonged release - 80 base milligrams

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

b & s healthcare - fluvastatin sodium - tablet prolonged release - 80 base milligrams

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

physicians total care, inc. - fluvastatin sodium (unii: pyf7o1fv7f) (fluvastatin - unii:4l066368as) - fluvastatin sodium 80 mg - therapy with lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol (see national cholesterol education program [ncep] treatment guidelines, below). lescol® (fluvastatin sodium) and lescol® xl (fluvastatin sodium) are indicated to reduce elevated total cholesterol (total-c), ldl-c, tg and apo b levels, and to increase hdl-c in patients with primary hypercholesterolemia and mixed dyslipidemia (fredrickson type iia and iib) whose response to dietary restriction of saturated fat and cholesterol and other nonpharmacological measures has not been adequate. lescol and lescol xl are indicated as an adjunct to diet to reduce total-c, ldl-c, and apo b levels in adolescent boys and girls who are at least one year post-menarche, 10-16 years of age, with heterozygous familial hypercholesterolemia whose response to dietary restriction has not been adequate and the following findings are present: - ldl-c remains > 190 mg/dl or - ldl-c remains > 160 mg/dl and:

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - fluvastatin sodium - modified-release tablet - 80mg

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

pco manufacturing - fluvastatin sodium - tablet prolonged release - 80 milligram

ナミビア - 英語 - Namibia Medicines Regulatory Council

novartis pharma s.a. - fluvastatin sodium - tablets - fluvastatin sodium equiv to fluvastatin free acid 80mg prolonged release tablets

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

carilion materials management - fluvastatin sodium (unii: pyf7o1fv7f) (fluvastatin - unii:4l066368as) - fluvastatin 80 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other non-pharmacologic measures alone has been inadequate. lescol and lescol xl are indicated - as an adjunct to diet to reduce elevated total cholesterol (total-c), low-density lipoprotein cholesterol (ldl-c), triglyceride (tg) and apolipoprotein b (apo b) levels, and to increase high-density lipoprotein cholesterol (hdl-c) in patients with primary hypercholesterolemia and mixed dyslipidemia (fredrickson type iia and iib). - as an adjunct to diet to reduce total-c, ldl-c, and apo b levels in adolescent boys and adolescent girls who are at least one year post-menarche, 10-16 years of age, with heterozygous familial hypercholesterolemia and the following findings are present:

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - fluvastatin sodium - tablet prolonged release - 80 milligram

マレーシア - 英語 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - fluvastatin -